Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $4,900 | 3 | 52.2% |
| Travel and Lodging | $1,647 | 7 | 17.6% |
| Unspecified | $1,500 | 1 | 16.0% |
| Food and Beverage | $865.33 | 8 | 9.2% |
| Consulting Fee | $466.67 | 1 | 5.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $6,894 | 13 | $0 (2020) |
| ModernaTX, Inc. | $1,500 | 1 | $0 (2022) |
| ZOLL Medical Corporation | $466.67 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $382.21 | 3 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $135.98 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,636 | 3 | ModernaTX, Inc. ($1,500) |
| 2020 | $1,517 | 3 | CSL Behring ($1,050) |
| 2019 | $4,794 | 5 | CSL Behring ($4,794) |
| 2018 | $50.74 | 1 | CSL Behring ($50.74) |
| 2017 | $1,382 | 8 | CSL Behring ($999.46) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2022 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls • Category: Infections and Infectious Diseases | ||||||
| 06/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $70.26 | General |
| 06/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $65.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2020 | CSL Behring | — | Honoraria | Cash or cash equivalent | $700.00 | General |
| 10/07/2020 | ZOLL Medical Corporation | — | Consulting Fee | Cash or cash equivalent | $466.67 | General |
| Category: DEFIBRILLATOR | ||||||
| 06/30/2020 | CSL Behring | — | Honoraria | Cash or cash equivalent | $350.00 | General |
| 12/06/2019 | CSL Behring | — | Honoraria | Cash or cash equivalent | $3,850.00 | General |
| 12/06/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $161.60 | General |
| 12/05/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $573.49 | General |
| 12/05/2019 | CSL Behring | — | Travel and Lodging | In-kind items and services | $149.00 | General |
| 12/05/2019 | CSL Behring | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 06/04/2018 | CSL Behring | — | Food and Beverage | In-kind items and services | $50.74 | General |
| 10/24/2017 | CSL Behring | Product in Development (Biological) | Travel and Lodging | Cash or cash equivalent | $186.13 | General |
| Category: Product in Development | ||||||
| 10/11/2017 | CSL Behring | Product in Development (Biological) | Travel and Lodging | In-kind items and services | $351.03 | General |
| Category: Product in Development | ||||||
| 10/11/2017 | CSL Behring | Product in Development (Biological) | Food and Beverage | In-kind items and services | $191.65 | General |
| Category: Product in Development | ||||||
| 10/11/2017 | CSL Behring | Product in Development (Biological) | Food and Beverage | In-kind items and services | $191.65 | General |
| Category: Product in Development | ||||||
| 10/11/2017 | CSL Behring | Product in Development (Biological) | Travel and Lodging | Cash or cash equivalent | $79.00 | General |
| Category: Product in Development | ||||||
| 08/25/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $123.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Travel and Lodging | In-kind items and services | $146.90 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $111.67 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3b, Open-Label, Safety and Immunogenicity Study of SARS CoV 2 mRNA-1273 Vaccine in Adult Solid Organ Transplant Recipients and Healthy Controls | ModernaTX, Inc. | $1,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 294 | 532 | $146,114 | $22,189 |
| 2022 | 20 | 526 | 1,098 | $255,821 | $37,113 |
| 2021 | 15 | 413 | 800 | $171,623 | $26,688 |
| 2020 | 16 | 464 | 813 | $187,957 | $31,044 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 20 | 22 | $9,328 | $1,625 | 17.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 35 | 36 | $5,624 | $1,264 | 22.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 13 | 21 | $12,390 | $1,190 | 9.6% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2020 | 33 | 33 | $1,276 | $441.40 | 34.6% |
| 82565 | Blood creatinine level | Office | 2020 | 15 | 58 | $2,958 | $239.71 | 8.1% |
| 84132 | Blood potassium level | Office | 2020 | 14 | 56 | $2,240 | $212.81 | 9.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 17 | 55 | $1,815 | $163.68 | 9.0% |
| 85048 | Automated white blood cell count | Office | 2020 | 14 | 57 | $3,192 | $116.63 | 3.7% |
| 85014 | Red blood cell concentration measurement | Office | 2020 | 14 | 57 | $2,394 | $108.44 | 4.5% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 11 | 37 | $1,554 | $101.56 | 6.5% |
About Dr. Didier Mandelbrot, M.D
Dr. Didier Mandelbrot, M.D is a Nephrology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295773596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Didier Mandelbrot, M.D has received a total of $9,379 in payments from pharmaceutical and medical device companies, with $1,636 received in 2022. These payments were reported across 20 transactions from 5 companies. The most common payment nature is "Honoraria" ($4,900).
As a Medicare-enrolled provider, Mandelbrot has provided services to 1,697 Medicare beneficiaries, totaling 3,243 services with total Medicare billing of $117,035. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Madison, WI
- Active Since 06/02/2006
- Last Updated 01/19/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1295773596
Products in Payments
- Moderna Covid-19 Vaccine (Biological) $1,500
- Product in Development (Biological) $999.46
- ZORTRESS (Drug) $382.21
- LIVTENCITY (Drug) $65.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Madison
Sandesh Parajuli, Mbbs, MBBS
Nephrology — Payments: $6,545
Dr. Sayee Sundar Alagusundaramoorthy, M.b.b.s.,, M.B.B.S.,
Nephrology — Payments: $6,245
Andrey Vavrenyuk, Md, MD
Nephrology — Payments: $1,161
Nolan Interial, Do, DO
Nephrology — Payments: $391.54
Roy Jhagroo, M.d, M.D
Nephrology — Payments: $375.62
Prabesh Aryal, Mbbs, MBBS
Nephrology — Payments: $103.09